Acuren Corp (NYSEAMERICAN:TIC) Given Consensus Recommendation of “Hold” by Analysts

Acuren Corp (NYSEAMERICAN:TICGet Free Report) has received a consensus rating of “Hold” from the six research firms that are presently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $14.3750.

A number of analysts have weighed in on the stock. JPMorgan Chase & Co. started coverage on shares of Acuren in a research note on Friday, January 9th. They set an “overweight” rating and a $16.00 target price on the stock. UBS Group reduced their price objective on Acuren from $15.00 to $11.50 and set a “neutral” rating on the stock in a research report on Friday, November 14th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $15.00 target price on shares of Acuren in a report on Friday, November 14th. Baird R W raised Acuren to a “hold” rating in a research note on Thursday, October 9th. Finally, Robert W. Baird initiated coverage on Acuren in a report on Thursday, October 9th. They set a “neutral” rating and a $15.00 price target on the stock.

Get Our Latest Analysis on Acuren

Hedge Funds Weigh In On Acuren

A number of hedge funds have recently modified their holdings of the business. Goldman Sachs Group Inc. bought a new stake in shares of Acuren in the first quarter worth $4,429,000. HB Wealth Management LLC bought a new stake in shares of Acuren in the 2nd quarter valued at about $166,000. KLP Kapitalforvaltning AS acquired a new stake in shares of Acuren in the second quarter valued at about $124,000. Amalgamated Bank acquired a new stake in shares of Acuren in the second quarter valued at about $39,000. Finally, ProShare Advisors LLC bought a new position in shares of Acuren during the second quarter worth about $234,000.

Acuren Stock Performance

TIC opened at $11.64 on Friday. The company’s 50 day moving average is $10.20 and its 200-day moving average is $11.22. Acuren has a 1-year low of $8.76 and a 1-year high of $14.94.

Acuren Company Profile

(Get Free Report)

Acuren Group Inc (NYSEAMERICAN:TIC) is a leading provider of non‐destructive testing (NDT), inspection, engineering and consulting services to the energy, petrochemical, manufacturing and infrastructure sectors. The company employs a range of advanced testing techniques—such as ultrasonic, radiographic, magnetic particle, liquid penetrant, eddy current and acoustic emission—to evaluate the integrity of pressure vessels, pipelines, storage tanks and other critical assets. By combining field inspections with laboratory analysis, Acuren helps clients identify defects, prevent equipment failures and meet regulatory requirements.

In addition to core NDT capabilities, Acuren offers specialty engineering and consulting services including fitness‐for‐service assessments, corrosion under insulation surveys, mechanical integrity programs, failure analysis and field machining.

Featured Articles

Analyst Recommendations for Acuren (NYSEAMERICAN:TIC)

Receive News & Ratings for Acuren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acuren and related companies with MarketBeat.com's FREE daily email newsletter.